Quant Score of 64.00000 Under the Microscope for SAMSUNG PHARM. Co., LTD. (KOSE:A001360)

SAMSUNG PHARM. Co., LTD. (KOSE:A001360) has a Q.i. Value of 64.00000. The Q.i. Value ranks companies using four ratios. These ratios consist of EBITDA Yield, FCF Yield, Liquidity, and Earnings Yield. The purpose of the Q.i. Value is to help identify companies that are the most undervalued. Typically, the lower the value, the more undervalued the company tends to be.

With so many different stock trading strategies to choose from, new investors may become overwhelmed when presented with all the possible options. Some investors will choose to rely on the expertise of professionals, while others will try to have a go at it on their own. Investors who prefer to do their own research and make their own investment decisions are quite common these days. Of course there is no set in stone way to properly trade the stock market. Markets and economic situations are constantly changing. Staying on top of all the latest information and global developments can be challenging. Investors who are able to stay the course and put in the required time might be able to eventually give themselves a leg up in the future.

Checking in on some valuation rankings, SAMSUNG PHARM. Co., LTD. (KOSE:A001360) has a Value Composite score of 61. Developed by James O’Shaughnessy, the VC score uses five valuation ratios. These ratios are price to earnings, price to cash flow, EBITDA to EV, price to book value, and price to sales. The VC is displayed as a number between 1 and 100. In general, a company with a score closer to 0 would be seen as undervalued, and a score closer to 100 would indicate an overvalued company. Adding a sixth ratio, shareholder yield, we can view the Value Composite 2 score which is currently sitting at 67.

Watching some historical volatility numbers on shares of SAMSUNG PHARM. Co., LTD. (KOSE:A001360), we can see that the 12 month volatility is presently 58.916900. The 6 month volatility is 40.404400, and the 3 month is spotted at 40.839200. Following volatility data can help measure how much the stock price has fluctuated over the specified time period. Although past volatility action may help project future stock volatility, it may also be vastly different when taking into account other factors that may be driving price action during the measured time period.

SAMSUNG PHARM. Co., LTD. (KOSE:A001360) has a current ERP5 Rank of 13263. The ERP5 Rank may assist investors with spotting companies that are undervalued. This ranking uses four ratios. These ratios are Earnings Yield, ROIC, Price to Book, and 5 year average ROIC. When looking at the ERP5 ranking, it is generally considered the lower the value, the better.

When the stock market is doing well, there may be plenty of winners in the portfolio. Figuring out when to sell a winner can be a tricky proposition. Many investors will be quick to take profits while others may want to hold out for further gains. Selling winners too early or holding on to winners too long may have a negative impact on the trading portfolio. Finding that balance between securing profits and holding out to take higher profits in the future can be very helpful for the active investor.

We can now take a quick look at some historical stock price index data. SAMSUNG PHARM. Co., LTD. (KOSE:A001360) presently has a 10 month price index of 0.63279. The price index is calculated by dividing the current share price by the share price ten months ago. A ratio over one indicates an increase in share price over the period. A ratio lower than one shows that the price has decreased over that time period. Looking at some alternate time periods, the 12 month price index is 0.70256, the 24 month is 0.68844, and the 36 month is 0.23122. Narrowing in a bit closer, the 5 month price index is 0.82779, the 3 month is 0.89689, and the 1 month is currently 0.87261.

Investors may be looking closely at current stock market levels as we move towards the closing stages of the year. Investors might be reviewing current holdings to see if there are any changes that need to be made. Even when things are going good with equities, it may be wise to regularly check the portfolio to make sure that everything is still balanced properly. Being prepared for various market conditions may be a great help to the investor when the winds of change eventually blow in.

Return on Assets

There are many different tools to determine whether a company is profitable or not. One of the most popular ratios is the “Return on Assets” (aka ROA). This score indicates how profitable a company is relative to its total assets. The Return on Assets for SAMSUNG PHARM. Co., LTD. (KOSE:A001360) is -0.008519. This number is calculated by dividing net income after tax by the company’s total assets. A company that manages their assets well will have a higher return, while a company that manages their assets poorly will have a lower return.

Return on Invested Capital (ROIC), ROIC Quality, ROIC 5 Year Average

The Return on Invested Capital (aka ROIC) for SAMSUNG PHARM. Co., LTD. (KOSE:A001360) is -0.059255. The Return on Invested Capital is a ratio that determines whether a company is profitable or not. It tells investors how well a company is turning their capital into profits. The ROIC is calculated by dividing the net operating profit (or EBIT) by the employed capital. The employed capital is calculated by subrating current liabilities from total assets. Similarly, the Return on Invested Capital Quality ratio is a tool in evaluating the quality of a company’s ROIC over the course of five years. The ROIC Quality of SAMSUNG PHARM. Co., LTD. (KOSE:A001360) is -0.046912. This is calculated by dividing the five year average ROIC by the Standard Deviation of the 5 year ROIC. The ROIC 5 year average is calculated using the five year average EBIT, five year average (net working capital and net fixed assets). The ROIC 5 year average of SAMSUNG PHARM. Co., LTD. (KOSE:A001360) is -0.090103.

FCF Yield 5yr Avg

The FCF Yield 5yr Average is calculated by taking the five year average free cash flow of a company, and dividing it by the current enterprise value. Enterprise Value is calculated by taking the market capitalization plus debt, minority interest and preferred shares, minus total cash and cash equivalents. The average FCF of a company is determined by looking at the cash generated by operations of the company. The Free Cash Flow Yield 5 Year Average of SAMSUNG PHARM. Co., LTD. (KOSE:A001360) is -0.119200.

Gross Margin score

Investors may be interested in viewing the Gross Margin score on shares of SAMSUNG PHARM. Co., LTD. (KOSE:A001360). The name currently has a score of 52.00000. This score is derived from the Gross Margin (Marx) stability and growth over the previous eight years. The Gross Margin score lands on a scale from 1 to 100 where a score of 1 would be considered positive, and a score of 100 would be seen as negative.

Traders may already have a favorite method for applying technical analysis. Active traders are typically concerned with shorter-term price movements when trading shares. Entry and exit points tend to be way more important for traders who are looking to capitalize on stock market trends. Some traders may opt to only use technical analysis when picking stocks, while others will also incorporate company fundamentals when doing research. Of course, there is no one foolproof method for trading the markets. Many technical investors will still opt to familiarize themselves with the fundamentals before diving deeper into the technical signals. Longer-term investors might not be as concerned with day to day price fluctuations while short-term traders may not want to miss out on any significant price swings. Whatever trading strategy is applied, investors may still want to try to get a sense of the overall picture before making the trade.